1. The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models – A systematic review
   Olivia J. Haller et al, 2023, Neuroscience & Biobehavioral Reviews CrossRef
2. Animal models of chemotherapy-induced cognitive decline in preclinical drug development
   Jeena John et al, 2021, Psychopharmacology CrossRef
3. Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions
   Melanie J. Sekeres et al, 2021, International Journal of Molecular Sciences CrossRef
4. Neurotoxicity of the antineoplastic drugs: “Doxorubicin” as an example
   Ghadha Ibrahim Fouad et al, 2024, Journal of Molecular Histology CrossRef
5. Dietary agents in mitigating chemotherapy-related cognitive impairment (chemobrain or chemofog): first review addressing the benefits, gaps, challenges and ways forward
   Shamprasad Varija Raghu et al, 2021, Food & Function CrossRef
6. Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma
   Jeena John et al, 2022, Scientific Reports CrossRef
7. Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα
   Nicole G. Rummel et al, 2021, Cellular and Molecular Life Sciences CrossRef
8. Neuroprotective effect of herbal extracts inhibiting soluble epoxide hydrolase (sEH) and cyclooxygenase (COX) against chemotherapy-induced cognitive impairment in mice
   Rachana Kulkarni et al, 2023, Biochemical and Biophysical Research Communications CrossRef